AdAlta secures licensing deal for the i-body platform with global medical technology and diagnostics firm, GE Healthcare
AdAlta secures commercial agreement for its i-body platform with global medical technology and diagnostics firm, GE Healthcare.
- AdAlta secures commercial agreement for its i-body platform with global medical technology and diagnostics firm, GE Healthcare.
- MELBOURNE, Australia, Sept. 16, 2019 /PRNewswire/ -- AdAlta Limited (ASX:1AD), today announced it has signed a commercial agreement for its i-body platformwith global medical technology firm, GE Healthcare.
- "We are thrilled to have secured this licensing deal with one of the world's largest healthcare companies.
- AdAlta has a proprietary technology platform to generate i-bodies, a new class of protein therapeutics, with applications as therapeutic drugs to treat disease.